Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Feb 15;11:3822. doi: 10.1038/s41598-021-83085-4

Improving the sexual activity and reproduction of female zebrafish with high testosterone levels

Congcong Liu 1,2,, Sophie Yue 2, Joshua Solarz 2, Jessica Lee 2, Lei Li 2,
PMCID: PMC7884839  PMID: 33589678

Abstract

High levels of testosterone cause clinical symptoms in female reproduction and possibly, alterations in sexuality. Yet, the underlying mechanisms remain to be examined. Here, we report a study that investigates the effects of testosterone in follicle development and sexual mating using zebrafish models. We developed an acute zebrafish model with high testosterone levels by exposing young female zebrafish to testosterone dissolved in swimming water. After given a high concentration of testosterone treatment (e.g., 100 ng/ml), the fish showed hallmark pathological symptoms similar to those displayed in patients with polycystic ovary syndrome (PCOS), such as follicular growth-arrest, rare ovulation, ovary enlargement, decrease in reproduction, and down regulation of the expression of some PCOS susceptible genes, such as Tox3. These fish are referred to as the PCOS fish. By monitoring mating-like swimming behaviors, we measured the sexual activity of PCOS zebrafish. In general, the PCOS fish showed no desire to interact with males. As a consequence, their mating rate was decreased as compared to control animals. The sexuality levels of PCOS fish, however, could be improved after short periods of rearing in conditions that lack of males. After only 3 days of rearing alone, the PCOS fish showed an increase in sexuality levels and displayed characteristic swimming patterns for mating. After 30 days of separation from males, not only the sexual activity, but also the mating rate was improved in the PCOS fish. Together, the data suggests that zebrafish can serve as a new type of research model to further develop strategies for the treatment of reproductive disorders, such as those related to PCOS.

Subject terms: Neuroscience, Diseases

Introduction

In humans, high levels of testosterone lead to active sexual behaviors in males but cause reproductive disorders in females, namely, polycystic ovary syndrome (PCOS)13. PCOS is characterized by hyperandrogenism, pathologic ovary, oligo-ovulation, which together, lead to clinical consequences such as infertility4,5. Previous studies have demonstrated that both genetic and epigenetic factors are attributed to the development of PCOS69. While gene mutations that cause PCOS have not been identified, a number of genetic loci that are susceptible to PCOS have been discovered10. Some of them, such as Tox3 and Dennd1a, are also involved in nervous system development and cell proliferation. In mouse cortical neurons, for example, the expression of Tox3 is required for calcium-dependent signaling transduction, which in turn, promotes synaptic formation and neural transmission11. In cultured human cancer cell lines, through intracellular epidermal growth factor pathways, the expression of Dennd1a facilitates cell migration and aggression12. Interruptions of endocrine pathways, particularly those involved in hormone synthesis and circulation, may also lead to increases in testosterone levels and the development of PCOS1317. In cultured mouse ovary granulosa cells, for example, accumulation of non-histone chromosomal proteins due to endocrine system malfunctions, which is commonly seen in human patients with high levels of testosterone, inhibits granulosa cell proliferation, which in turn, causes follicular growth-arrest and PCOS18.

Treatments for high levels of testosterone in females are widely available, which include hormone adjustment (e.g., to lower the level of androgen and restore menstrual regularity) and ovulation therapy (e.g., to stimulate follicle maturation)1925. They are effective in solving the occurrence of short-term complications, but can sometimes cause serious side effects, such as ovarian hyperstimulation, hyperkalemia, or liver damage26.

Animal models, which include mice, rats, and sheep, have been previously described for studying human reproductive disorders caused by high levels of testosterone2729. Recently, zebrafish have emerged as an alternative model organism for studying human diseases3033. Zebrafish are vertebrate organisms with approximately 70% genetic homology to humans34. They have a relatively short sexual maturation time (2 months), and a rapid recovery period of ovulation (1–2 week). A young female can lay several hundreds of eggs every other week35,36. The eggs are fertilized in water and the embryos are transparent and develop externally, making them an excellent model for studying developmental biology. Zebrafish have a small body size (e.g., adult zebrafish is approximately 1-inch long) and move slowly (e.g., 1–3 cm per second), and their behaviors can be readily observed37. Here, we report a study of follicle development and sexual mating in female zebrafish with a high level of testosterone. We proposed that high levels of testosterone interrupt the pathways of signal transduction involved in ovulation and sexuality, which in turn, decreases reproduction. We developed acute zebrafish models with high levels of testosterone, referred to as PCOS fish, and characterized the zebrafish models using molecular, histologic, and behavioral assays. In addition, we developed methods for improving the mating rate and reproductivity in PCOS fish. Together, the data suggests that zebrafish can be used for studying the mechanisms of human diseases involved in female reproduction.

Materials and methods

Animal care

Zebrafish colonies (AB strain, between 3 and 8 months of age) were maintained in the fish facility in accordance with the animal protocol approved by the University of Notre Dame IACUC (Protocol #, 17-11-4243). The fish were maintained in 5-L tanks (40 fish per tank, males and females were intermixed) with circulating water (distilled water with instant ocean added, 3 mg/l; pH = 7.0 ± 0.2), in which approximately 10% of the total volume was renewed each day. The male and female fish were identified based on their sexual dimorphisms (e.g., body shape, skin color). The fish facility was set at 28 ± 0.5 °C (room temperature) and illuminated with fluorescent ceiling light in 14:10 light–dark cycles (light on, 7AM; light off, 9PM). The fish were fed twice a day with freshly hatched brine shrimps. The health of zebrafish and the quality of the water were monitored by certified veterinarians and animal-care personnel on a daily basis. For each set of the experiments involving testosterone treatment, histology, and qRT-PCR, 5–8 animals were used. For each set of the behavioral tests, 8–12 animals were used. The studies reported in this paper were conducted in compliance with the ARRIVE guidelines, and the methods were carried out in accordance with the NIH regulations. Major experimental procedures are demonstrated in Fig. S1.

Testosterone treatment

Testosterone (Biorular, Danbury, USA) was dissolved in distilled water (2.0 × 104 ng/ml) that contained 0.1% dimethyl sulfoxide (DMSO) and stored at − 20 °C. DMSO was used to dissolve testosterone38. Prior to each treatment, desired amounts of testosterone stock solutions were added to containers that contained 1000 ml fish water to make the final testosterone concentration at 0.25, 2, 10, or 100 ng/ml. Female zebrafish (20 fish per tank) were allowed to swim in the container under normal rearing conditions (14:10 light–dark cycle, 28 °C, normal feeding) for 3 consecutive days, and the drug solutions were changed once a day. During the treatment, no signs of stress and/or discomfort were observed in individual animals (e.g., jerky movement or remaining still at the bottom of the container). Control treatment was conducted in 0.1% DMSO dissolved in regular facility water. Unless specified, the experiments were conducted using zebrafish that were treated with 100 ng/ml testosterone because this dose of treatment caused significant changes (e.g., gene expression, ovary histology, and sexual activity) as compared to control animals.

After testosterone treatment, the fish were either kept alone or intermixed with males for 3, 14, 30, or 60 days before they were transferred to the mating cage that contained male animals. They were then tested for sexual mating and reproduction.

Measuring the testosterone levels

Zebrafish were anaesthetized and sacrificed in 1% tricaine mesylate (Sigma-Aldrich, MO, USA) dissolved in water at 4 °C in accordance with the approved animal protocols. Ovary and brain tissues were isolated, weighed, and homogenized using methanol (75% in water; 1 µg tissue in 1 µl solution). Samples were centrifuged at 2000g in 4 °C, and the supernatants were collected. These procedures were repeated 3 times, and the supernatants were combined and lyophilized with vacuum and stored in − 80 °C. Testosterone levels were measured using the gas chromatography-mass spectrometry (GCT Premier Mass Spectrometer, coupled with an Agilent 6890 Gas Chromatograph fitted with 7683B Series Injector) in accordance with the manufacturer’s instruction (Waters Corporation, Milford, USA).

Histology and classification of follicles

Zebrafish was anaesthetized and sacrificed in accordance with the approved animal protocols. Ovaries were dissected and fixed in 4% paraformaldehyde overnight at 4 °C. After dehydration in 80%, 90%, 95%, 100% ethanol and 100% xylene, specimens were embedded in paraffin and frozen at − 20 °C. Sections of 6 μm thickness were collected onto glass slides, air dried, stained with hematoxylin and eosin, and shielded with cover glass. In each ovary, 8 sections at 6 μm intervals were collected.

The sections were examined under a microscope. Based on the size of follicles and the distribution of endocrine contents in surrounding tissues, the follicles were assigned into five groups, which represent the developing, transitioning, and mature follicles39. Stage I: primary growth stage, follicle diameter < 140 μm, surrounded by a flat layer of pre-follicle cells; Stage II: cortical alveolus stage, follicle diameter 140–340 μm, basophilic vesicles presented in the cytoplasm of the oocyte; Stage III: vitello genesis stage, follicle diameter 340–690 μm, eosinophilic vesicles presented in cytoplasm of the oocyte; Stage IV: oocyte maturation stage, follicle diameter 690–730 μm, yolk granular cells could be found in cytoplasm of the oocyte; Stage V: mature eggs, diameter > 730 μm, yolk granules could be found in the cytoplasm of the oocyte. From each section, between 30 and 80 follicles were examined depending on the size of the section.

Reverse transcription and qRT-PCR

RNA was extracted from the isolated ovary and brain using the Trizol reagent kit (Thermo Fisher, Waltham, USA). Using the PrimeScript RT kit with gDNA Eraser (Takara, Dalian, China), 1 μg of total RNA was converted into cDNA. Reactions in 10 μl volume containing 1 μl of cDNA, 5 μl of SYBR green master mix, 1 μl of primer mix, and 3 μl of RNase-free water per sample were conducted using Light Cycler 480 (Roche Applied Science, Basel, Switzerland) with SYBR Premix ExTaq (Takara, Dalian, China) in the following steps: 10 min at 95 °C, followed by 40 cycles of 10 s at 95 °C, 20 s at 60 °C, 10 s at 72 °C. The primer sequences were: Actin: forward: 5′-CAGCCTTCC TTCCTGGGTA-3′, reverse: 5′-TGGCATACAGGTCCTTACGG-3′. Tox3: forward: 5′-GTCTGCATA TGCCCTGTTCT-3′, reverse: 5′-TCCCACATGGAGGCTACTAT-3′; Dennd1a: forward: 5′-CGCTAT CCAGCTACAGTTCTTC-3′, reverse: 5′-CCATGTTGATCTCCTCCTCAAA-3′; Reaction products were analyzed by comparative C(T) to determine the relative gene expression levels.

Measuring the gonado-somatic index

The gonado-somatic index (GSI) has been previously used as a criterion for evaluating the development and function of ovaries in animal models40. We measured the GSI in both the control and testosterone-induced PCOS zebrafish. The fish was anaesthetized, wiped and dried with a paper towel, and weighed. Then, the fish was sacrificed and the ovaries were dissected and weighed. The GSI was calculated as the following: GSI = ovary weight (g)/body weight (g).

Videotaping and scoring the sexuality activity

Zebrafish swimming behaviors were videotaped using a camcorder (Sony, CX440) set on a tripod. Recording were made in the early morning, between 07:00 and 07:30 AM, during which time natural mating occurs36,37. In the evening before videotaping, the male and female fish (either a control or testosterone-treated PCOS fish) were transferred to the mating cage (20.3 cm width × 7.6 cm depth × 7.6 cm height). Each cage hosted one male fish and one female fish. The mating cage was divided into two sections by an aluminum screen inserted in the middle of the cage. The screen permitted water flow but separated the male and female fish, preventing them from making physical contact with each other. Each half of the cage was further partitioned into 3 sections by lines marked on a paper that was placed underneath the cage. The lines could be visualized through the bottom of the transparent cage. This was to indicate the areas related to the net in the middle of the mating cage.

On the day of the experiment, immediately after light on-set in the morning, we videotaped the fish for 30 min. After videotaping, we analyzed the swimming behaviors of the female fish to determine its tendency for mating. Specifically, we quantified the animal’s desire for mating, referred to the “sexuality levels”41. Several measures were put in place to indicate the animal’s sexuality levels. First, we monitored the locations where the fish swam at 15-s intervals. If the fish swam in the section that was closest to the net in the middle of the cage (which was close to the male fish that swam in other half of the cage), the fish was given a score of 5 points; if the fish swam in the middle section of its compartment, the fish was given a score of 3 points; if the fish was recorded in the third section which was farthest from the net, the fish was given a score of 0 points. Second, we determined the speed of fish swimming at 15-s intervals. This was done by measuring the distance (in centimeters) the fish swam in a 1-s period. Fast swimming (e.g., > 3.0 cm/s) valued 2 points, normal swimming (between 1.0–3.0 cm/s) earned 1 point, and slow swimming (e.g., < 1.0 cm/s) received 0 points. Third, we counted the number of times the fish attempted to cross the middle line of the cage (e.g., the number of times the fish approached the net). Each time the fish swam against the net (i.e., physical contact), the fish received an additional 5 points. Total scores were summed for individual fish to indicate its sexuality levels. In all cases, the analysis of fish behaviors on the videotape was performed by researchers who possessed no knowledge of the origins and conditions of the fish (i.e., if the fish on the video was a PCOS fish or a control fish).

Mating

After videotaping the swimming behaviors, the net in the middle of the mating cage was removed and the female and male zebrafish were allowed to mate for 1 h. The number of females that laid eggs, the number of eggs that spawned from each mating, and the number of embryos that hatched at 5 days post-fertilization were counted.

Statistical analysis

Data was analyzed using the IBM SPSS Statistics 23.0 and assessed by the Kolmogorov–Smirnov test to determine whether the continuous variables were normally distributed. Normally distributed data was analyzed using the Student’s t test, and nonparametric data was analyzed using the Mann–Whitney U test. Statistically significant differences were considered when the p value was smaller than 0.05 (two-tailed).

Results

Creating female zebrafish with high levels of testosterone

To create acute female zebrafish models with high levels of testosterone, we treated young adult female fish with different concentrations of testosterone (0, 0.25, 2, 10, and 100 ng/ml) applied to swimming water. After 3 consecutive days of treatment, we isolated their ovary and brain tissues and measured testosterone levels. When treated with a lower concentration of testosterone (e.g., 0 ng/ml and 0.25 ng/ml), no changes in testosterone levels were observed in either organ. With the increase of treatment concentration (e.g., 2 ng/ml and 10 ng/ml), slight increases in testosterone levels were observed, but the differences were not statistically significant as compared to control samples. In zebrafish treated with the highest concentration of drugs (e.g., 100 ng/ml), significant increases of testosterone levels were detected (e.g., 74.5% in the ovary and 86.3% in the brain). Zebrafish that showed significant increases in testosterone levels in the ovaries and in the brain after treatment with 100 ng/ml testosterone were thereby referred to as “PCOS zebrafish” (Fig. 1).

Figure 1.

Figure 1

Testosterone levels in isolated ovary (A) and brain (B) tissues in control (black bars) and drug treated (grey bars) animals. Note the increase of testosterone levels after drug treatment. Data represents the means ± SE (n = 5 in each group). *p < 0.05; **p < 0.01; ns not significant.

PCOS zebrafish showed defects in follicle maturation and ovulation

In control zebrafish, developing (Stage I and Stage II), transitioning (Stage III), and mature (Stages IV and V) follicles can be readily identified (Fig. 2A). In PCOS zebrafish, due to follicular growth-arrest, more follicles remained at developing stages as compared to control animals. While the number of transitioning follicles was similar between the PCOS and control animals, the amount of mature follicles in PCOS fish was significantly reduced (Fig. 2B). In addition, in PCOS fish, atretic follicles were observed, accompanied by other types of defective follicles, such as deformation of zona radiate membranes, detachment of zona radiate from granular cells, invasion of hypertrophy and hyperplasia granulose cells, and accumulation of basophilia materials (Fig. 2C,D). In control fish, the percentages of developing, transitioning, and mature follicles accounted for 72.1%, 16.6%, and 11.3% of total follicles, whereas in PCOS fish, they accounted for 82.3%, 13.4%, and 4.3% of total follicles (Fig. 2E). Due to the decrease in the number of mature follicles, ovulation in PCOS fish was also dropped by 57.7% compared to control animals (Fig. 2F).

Figure 2.

Figure 2

Follicle development and ovulation in control and PCOS zebrafish. (A,B) Histological sections of the ovary. In control fish (A), follicles at different stages could be identified. These include developing follicles (Stages I and II, black and green arrows), transitioning follicles (Stage III, red arrows), and mature follicles (Stages IV and V, red and black asterisks). In PCOS fish (B), more developing follicles but less mature follicles were observed. (C,D) Histological sections that show abnormal follicles in PCOS fish. These include zona pellucida invagination (black arrow), theca hypertrophy/granulosa cell invagination (blue arrow), basal membrane disintegration (red arrow), and basophilic granular accumulation (green arrow). Scale bar: 100 µm in panels (A) and (B), and 50 µm in panels (C) and (D). (E) Percentage of developing, transitioning, and mature follicles in control (black bars) and PCOS fish (grey bars). Note the increase of developing follicles and the decrease of mature follicles in PCOS animals. (F) Ovulation in control (black bar) and PCOS (grey bar) zebrafish. Note the decrease of ovulation in PCOS fish. Data represents the means ± SE (n = 8 in each group). *p < 0.05; **p < 0.01; ns not significant.

In PCOS fish, the ovaries were enlarged. This was revealed by the increase of the gonadosomatic index (GSI). In control fish, the GSI was 0.14 ± 0.01, whereas in PCOS fish, the GSI increased to 0.16 ± 0.01 (p < 0.05; Fig. S2A).

Abnormal gene expressions in PCOS zebrafish

To verify the applicability of testosterone-induced zebrafish as a model for PCOS, we examined the expression of two PCOS susceptible genes, Tox3 and Dennd1a, in the control and PCOS animals. In isolated ovary and brain tissues, the expression of Tox3 was decreased by 43.1% and 36.5%, respectively, in PCOS fish in comparison to its expression in control samples (p < 0.05; Fig. 3A). The expression of Dennd1a was also decreased in PCOS fish as compared to its expression in control samples (by 38.9% and 28.3%), but the decrease in either organ was not statistically significant (p > 0.05; Fig. 3B).

Figure 3.

Figure 3

The expression of Tox3 (A) and Dennd1a (B) in isolated ovary and brain tissues from the control (black bars) and PCOS (grey bars) animals. The expression of Tox3 and Dennd1a in the control sample was normalized to 1, and their expression in PCOS fish was compared to the base value of 1. Note the decrease of Tox3 expression in PCOS samples. However, no significant changes in Dennd1a expression were detected. Data represents the means ± SE (n = 8 in each group). *p < 0.05; ns not significant.

POCS zebrafish showed reduced sexuality levels and mating rates

We examined the sexual and mating behaviors of the control and PCOS fish. In the control experiment (e.g., a control female fish and a control male fish that were placed in the same cage, but separated by a net in the middle of the cage; see Fig. 4A, top panel), for much of the time during the 30-min recording period, both the female and male fish swam in areas close to the net. Often, the fish increased their swimming speed and bumped into the net in an attempt to interact with each other. In the experimental setting (a PCOS female and a control male that were placed in the mating cage, but separated by a net in the middle of the cage; see Fig. 4A, bottom panel), the PCOS fish showed no preference to swim in areas that are close to the net. Instead, for most of the time during the 30-min recording period, the PCOS fish slowly and randomly swam in all areas of its compartment. Based on their swimming behaviors (i.e., affinity to areas that were close to the net, speed of swimming, and number of times the fish bumped to the net), we scored the sexuality levels (i.e., the intention for mating) of the control and PCOS animals. As compared to control fish, the sexuality levels of PCOS fish were decreased by 68.3% (Fig. 4B).

Figure 4.

Figure 4

Swimming patterns, sexuality scores, and mating rates of control and PCOS zebrafish. (A) Static positions of control (top panel, red circles) and PCOS fish (bottom panel, red circles) at 15-s intervals during a 30-min recording period in the morning. Bold dashed lines indicate the net. In the control setting, the female showed preferences to swim in areas close to the net. In the experimental setting, the PCOS fish swam in all areas, either near or far from the net. Blue circles show the static positions of the male fish at 15-s intervals. (B) Sexuality scores of control females (black bar) and PCOS fish (grey bar). The sexuality levels of control fish were normalized to 1, and the sexuality levels of PCOS fish were compared to the base value of 1. Note the decrease in sexuality levels in PCOS fish. (C) Mating rates of control (black bar) and PCOS fish (grey bar). Note the decrease of mating in PCOS fish. Data represents the Means ± SE (n = 12 in each group). **p < 0.01.

After the behavioral tests, we removed the net in the middle of the cage and allowed the fish to mate for one hour. We calculated the mating rate of PCOS and control fish (percentage of PCOS fish that laid eggs after natural mating) and determined the hatching rate of developing embryos from each mating (e.g., percentage of embryos spawn at 5 days post-fertilization). In PCOS fish, both the mating (Fig. 4C) and hatching rates (Fig. S3A) were decreased as compared to control animals.

Increase of sexuality levels and reproduction in PCOS fish after rearing in separation from males

We developed a scheme that kept PCOS fish under different rearing conditions (e.g., either reared alone, or intermixed with males) to test the potential improvement of sexuality and reproduction. After 3 days of rearing alone (one fish per tank, with normal feeding schedules), the PCOS fish showed increased sexuality levels as compared to the PCOS fish that had been previously intermixed with male animals. For example, when they were tested in the mating cage that contained male animals, during the 30-min behavioral test period, the PCOS fish that had been previously reared alone spent more time swimming in areas next to the net in an attempt to mate with the male fish (Fig. 5A; left top panel). In contrast, the PCOS fish that had been previously intermixed with males swam around in all areas in the mating cage, and they showed no preference for swimming next to the net (Fig. 5A; left bottom panel). The change of swimming behaviors was also observed in PCOS fish reared alone for 14, 30, and 60 days (Fig. 5B–D; left top panels). In PCOS fish that were intermixed with males, after 14, 30, and 30 days of rearing, when they were tested for mating behaviors, no obvious changes in swimming patterns were observed; they showed no preference for swimming next to the net in an attempt to mate with the male (Fig. 5B–D; left panels).

Figure 5.

Figure 5

Swimming patterns, sexuality levels, and mating rates of PCOS zebrafish after 3 days (A), 14 days (B), 30 days (C), and 60 days (D) of rearing in different conditions. Left panels showed the static positions of the fish at 15-s intervals during the 30-min recording period. Bold dashed lines indicate the net. In all cases, the PCOS fish that had been previously kept alone displayed preferences to swim in areas close to the net. In contrast, the PCOS fish that had been previously kept with males swam randomly in all areas. Middle panels showed relative sexuality scores of PCOS fish that had been previously kept alone (black bars) or intermixed with males (grey bars). The scores of PCOS zebrafish kept alone were normalized to 1, and the scores of PCOS zebrafish that were kept with males were compared to the base value of 1. Note the decrease in sexuality levels in PCOS fish reared intermixed with males. Right panels showed the mating rate of PCOS zebrafish after they were kept alone (black bars) or intermixed with males (grey bars). After 3 or 14 days of rearing under different conditions, no statistical differences were detected in the mating rates. After 30 or 60 days of different rearing, the mating rate was increased in PCOS fish that had been previously reared alone as compared to PCOS fish that had been previously reared intermixed with males. Data represents the means ± SE (n = 8 in each group). *p < 0.05; **p < 0.01; ns not significant.

Based on their swimming patterns (when tested in the mating cage with males), we calculated the sexuality levels of PCOS zebrafish that had been maintained under different conditions (either alone or intermixed with males). In all cases (e.g., after 3, 14, 30, or 60 days of different rearing), the sexuality levels of PCOS fish that had been reared alone were significantly higher than the sexuality levels of PCOS fish that had been previously reared intermixed with male animals (Fig. 5A–D; middle panels).

To demonstrate if the increase in sexuality of PCOS fish reared alone may correlate with the gradual recovery of ovary functions, we compared the GSI of PCOS fish that had been reared under different conditions. After 3 or 14 days rearing alone or intermixed with males, no significant differences were detected in the GSI in PCOS fish. After 30 or 60 days of differential rearing, the GSI was significantly decreased in PCOS fish that had been kept alone as compared to the GSI in PCOS fish that had been kept intermixed with males (Fig. S2B–E).

To assess whether the fertility levels were changed in PCOS fish that had been maintained under different conditions, PCOS fish were allowed to mate with males for 1 h. From each pair-wised sexual mating, we counted the number of PCOS fish that laid eggs, the number of eggs from each mating, and the number of eggs that were spawned at 5 days post-fertilization. After 3 or 14 days of different rearing, we observed no significant differences in the mating rate between the PCOS zebrafish that had been previously reared alone or intermixed with males (Fig. 5A,B; right panels). When tested after 30 or 60 days of rearing under different conditions, the mating rate was increased in PCOS fish that had been previously reared alone as compared to the mating rate in PCOS fish that had been previously reared intermixed with males (Fig. 5C,D; right panels). In all cases, however, the hatching rate remained unchanged regardless of whether the PCOS fish had been previously kept alone or intermixed with males (Fig. S3B–E).

Discussion

Testosterone has been known as one of the most influential factors in regulating sexual behaviors in males1,4246. The relationship between testosterone and female sexual activity has also been examined, but the conclusion is ambiguous47,48. Some research (e.g., in monkeys) suggests that testosterone is not associated with sexual motivation in females49. Other research indicates that androgens (including testosterone) are required for female sex activity. For example, in adrenal-ectomized female monkeys, in which the production of testosterone was decreased, their sexual receptivity and mating rate were decreased50. While the underlying mechanisms remain to be further studied, it is possible that testosterone plays an important role in the modulation of sexual hormone circulation in the brain in females.

In humans, there is no direct evidence that correlates the total testosterone levels and female sexual activities. Some studies suggested that high testosterone levels (e.g., in PCOS patients) do not affect the sexual desires in women51. In other studies, it is found that testosterone increases the sexual desire in women by enhancing the function of female-specific hormones, such as estrogen52. Our data suggests that, based on the behavioral studies using PCOS zebrafish models, higher levels of testosterone reduce the sexual activity in females. For example, after treatment with a high concentration of testosterone (e.g., 100 ng/ml), when encountering male animals, the PCOS fish showed no desire to initiate or engage in sexual copulation. We did not detect histological (follicle distribution and maturation in the ovary) or behavioral (sexual mating) changes in female zebrafish that were treated with lower concentrations of testosterone (e.g., 0.25, 2, and 10 ng/ml).

While the total number of the follicles in PCOS and control fish were similar, in PCOS fish, the majority of the follicles remained in Stages I and II, while the number of mature follicles (e.g., those in Stages IV and V) were decreased. This may be due to the malfunction of endocrine signal transduction in the ovary, by which the process of follicle maturation is arrested. The increase of GSI in PCOS fish supports the notion that high levels of testosterone cause molecular and cellular abnormalities in the ovary. We showed that high levels of testosterone interrupt the patterns of gene expression associated with PCOS (Fig. 3). Previous studies have shown that both genes are involved in cell development and proliferation1012. The decrease of Tox3 expression may be attributed to the arrest of follicle development and maturation in testosterone treated animals.

Due to the aforementioned molecular, cellular, and tissue abnormalities, the PCOS fish show defects in sexual activity and reproduction (Fig. 4). Under certain circumstances (i.e., by rearing the PCOS fish alone instead of mixing them with males), however, the sexuality levels of PCOS fish may be increased. While the underlying mechanisms remain to be further studied, it is possible that the increase in sexuality is due to the recovery of ovary functions. For example, after 30 days of rearing alone, the GSI was reduced (Fig. S2), the testosterone level was dropped (Fig. S4A), and the number of atretic follicles was decreased (Fig. S4B). We did not detect differences in the hatching rate between the PCOS fish that had been reared alone or intermixed with males (Fig. S3), suggesting that alterations in sexual behaviors may not impact the condition of mature follicles.

It was noticed that in the mating experiments involved with PCOS females, the male zebrafish became less-interested in engaging in sexual behaviors. For example, during the 30-min recording period, the male fish spent less time swimming in areas next to the net as compared to the male fish in the control setting (see Fig. 5). This may be caused by alterations in testosterone levels in the male fish when it encountered a female fish with higher levels of testosterone. Previous studies have shown that in men, the testosterone levels may be varied in accordance with the ovulating state of women. That is, males who were exposed to scents of ovulating females recorded higher testosterone levels than males who were exposed to scents of non-ovulating females53. It is possible that, in our experiments, after being exposed to a female (e.g., the PCOS fish) with decreased ovulating cues, the testosterone levels in male fish were decreased, which in turn, decreased their motivation to engage in sexual mating.

In summary, we demonstrate that zebrafish is an excellent model for studying reproductive diseases, such as PCOS. Previously, zebrafish have been used for research in human reproductive systems. Most of those studies emphasized for understanding the molecular and cellular mechanisms involved in the etiology and/or pathology of the diseases, such as defects in gene expression5459, signal transduction6064, cell metabolism6569, or hormone regulation7074. Our study suggests that zebrafish can also be a model system for behavioral studies of human reproductive system diseases. The newly developed schemes (e.g., rearing the PCOS fish alone rather than mixed with males) may provide the proof-of-concept for developing new strategies for treatment of PCOS.

Supplementary Information

Supplementary Information. (332.6KB, docx)

Acknowledgements

The authors thank Deb Bang for maintaining the zebrafish colonies. The research was supported in part by grants from the National Science Foundation of China (81671242) and the US Department of Defense (W911NF-18-1-0292).

Author contributions

C.L. and L.L. wrote the main manuscript, C.L., S.Y., and J.S. conducted the experiment, C.L., J.L. and L.L. performed the statistical analysis. All authors reviewed the manuscript.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Congcong Liu, Email: 201920647@mail.sdu.edu.cn.

Lei Li, Email: Li.78@nd.edu.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-021-83085-4.

References

  • 1.Shabsigh R. Testosterone therapy in erectile dysfunction and hypogonadism. J. Sex. Med. 2005;2:785–792. doi: 10.1111/j.1743-6109.2005.00139.x. [DOI] [PubMed] [Google Scholar]
  • 2.Escobar-Morreale HF. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 2018;14:270–284. doi: 10.1038/nrendo.2018.24. [DOI] [PubMed] [Google Scholar]
  • 3.Kumarendran B, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018;15:e1002542. doi: 10.1371/journal.pmed.1002542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 2015;36:487–525. doi: 10.1210/er.2015-1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 2011;7:219–231. doi: 10.1038/nrendo.2010.217. [DOI] [PubMed] [Google Scholar]
  • 6.Filippou P, Homburg R. Is foetal hyperexposure to androgens a cause of PCOS? Hum. Reprod. Update. 2017;23:421–432. doi: 10.1093/humupd/dmx013. [DOI] [PubMed] [Google Scholar]
  • 7.Saenz-de-Juano MD, et al. DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients. Hum. Reprod. 2019;34:1640–1649. doi: 10.1093/humrep/dez121. [DOI] [PubMed] [Google Scholar]
  • 8.Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 2012;44:1020–1025. doi: 10.1038/ng.2384. [DOI] [PubMed] [Google Scholar]
  • 9.Zhao, H. et al. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Hum. Reprod.27, 294–298 (2012). [DOI] [PubMed]
  • 10.Louwers YV, Stolk L, Uitterlinden AG, Laven JS. Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2013;98:E2006–2012. doi: 10.1210/jc.2013-2495. [DOI] [PubMed] [Google Scholar]
  • 11.Yuan SH, Qiu Z, Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc. Natl. Acad. Sci. USA. 2009;106:2909–2914. doi: 10.1073/pnas.0805555106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ye B, et al. EGF stimulates rab35 activation and gastric cancer cell migration by regulating DENND1A-Grb2 complex formation. Front. Pharmacol. 2018;9:1343. doi: 10.3389/fphar.2018.01343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Caldwell ASL, et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA. 2017;114:3334–3343. doi: 10.1073/pnas.1616467114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dulka EA, Moenter SM. Prepubertal Development of gonadotropin-releasing hormone neuron activity is altered by sex, age, and prenatal androgen exposure. Endocrinology. 2017;158:3943–3953. doi: 10.1210/en.2017-00768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Escobar-Morreale, H. F., Luque-Ramirez, M. & San Millan, J. L. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr. Rev.26, 251–282 (2005). [DOI] [PubMed]
  • 16.Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 2016;37:467–520. doi: 10.1210/er.2015-1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New perspectives on the pathogenesis of PCOS: Neuroendocrine origins. Trends Endocrinol. Metab. 2018;29:841–852. doi: 10.1016/j.tem.2018.08.005. [DOI] [PubMed] [Google Scholar]
  • 18.Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum. Reprod. Update. 2004;10:107–117. doi: 10.1093/humupd/dmh010. [DOI] [PubMed] [Google Scholar]
  • 19.Kalem MN, Kalem Z, Gurgan T. Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles. J. Endocrinol. Invest. 2017;40:745–752. doi: 10.1007/s40618-017-0634-x. [DOI] [PubMed] [Google Scholar]
  • 20.Misso ML, et al. Aromatase inhibitors for PCOS: A systematic review and meta-analysis. Hum. Reprod. Update. 2012;18:301–312. doi: 10.1093/humupd/dms003. [DOI] [PubMed] [Google Scholar]
  • 21.Lagana AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: Restoring fertility through a pathophysiology-based approach. Trends Endocrinol. Metab. 2018;29:768–780. doi: 10.1016/j.tem.2018.09.001. [DOI] [PubMed] [Google Scholar]
  • 22.Legro R. Diagnosis and treatment of polycystic ovary syndrome (PCOS): An interview with Richard Legro. BMC Med. 2015;13:64. doi: 10.1186/s12916-015-0299-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lovvik TS, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): A randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7:256–266. doi: 10.1016/S2213-8587(19)30002-6. [DOI] [PubMed] [Google Scholar]
  • 24.Orio F, Palomba S. Reproductive endocrinology: New guidelines for the diagnosis and treatment of PCOS. Nat. Rev. Endocrinol. 2014;10:130–132. doi: 10.1038/nrendo.2013.248. [DOI] [PubMed] [Google Scholar]
  • 25.Wei D, et al. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome. Hum. Reprod. 2017;32:354–361. doi: 10.1093/humrep/dew325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gorry A, White DM, Franks S. Infertility in polycystic ovary syndrome: Focus on low-dose gonadotropin treatment. Endocrine. 2006;30:27–33. doi: 10.1385/ENDO:30:1:27. [DOI] [PubMed] [Google Scholar]
  • 27.Bertoldo MJ, et al. A hyperandrogenic environment causes intrinsic defects that are detrimental to follicular dynamics in a PCOS mouse model. Endocrinology. 2019;160:699–715. doi: 10.1210/en.2018-00966. [DOI] [PubMed] [Google Scholar]
  • 28.Quandt LM, Hutz RJ. Induction by estradiol-17 beta of polycystic ovaries in the guinea pig. Biol. Reprod. 1993;48:1088–1094. doi: 10.1095/biolreprod48.5.1088. [DOI] [PubMed] [Google Scholar]
  • 29.Zhang C, Ma J, Wang W, Sun Y, Sun K. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome. Hum. Reprod. 2018;33:2096–2106. doi: 10.1093/humrep/dey292. [DOI] [PubMed] [Google Scholar]
  • 30.Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005;4:35–44. doi: 10.1038/nrd1606. [DOI] [PubMed] [Google Scholar]
  • 31.Lieschke GJ, Currie PD. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 2007;8:353–367. doi: 10.1038/nrg2091. [DOI] [PubMed] [Google Scholar]
  • 32.Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV. Zebrafish models for translational neuroscience research: From tank to bedside. Trends Neurosci. 2014;37:264–278. doi: 10.1016/j.tins.2014.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 2014;35:63–75. doi: 10.1016/j.tips.2013.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Howe K, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498–503. doi: 10.1038/nature12111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995;203:253–310. doi: 10.1002/aja.1002030302. [DOI] [PubMed] [Google Scholar]
  • 36.Lawrence C. Advances in zebrafish husbandry and management. Methods Cell Biol. 2011;104:429–451. doi: 10.1016/B978-0-12-374814-0.00023-9. [DOI] [PubMed] [Google Scholar]
  • 37.Spence R, Gerlach G, Lawrence C, Smith C. The behaviour and ecology of the zebrafish, Danio rerio. Biol. Rev. Camb. Philos. Soc. 2008;83:13–34. doi: 10.1111/j.1469-185X.2007.00030.x. [DOI] [PubMed] [Google Scholar]
  • 38.Melong N, et al. Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia. Sci. Rep. 2017;7:14698. doi: 10.1038/s41598-017-14413-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Anil S, Rawson D, Zhang T. Development of molecular markers for zebrafish (Danio rerio) ovarian follicle growth assessment following in-vitro culture in cryopreservation studies. Cryobiol. 2018;83:75–83. doi: 10.1016/j.cryobiol.2018.05.004. [DOI] [PubMed] [Google Scholar]
  • 40.Van den Belt K, Wester PW, van der Ven LT, Verheyen R, Witters H. Effects of ethynylestradiol on the reproductive physiology in zebrafish (Danio rerio): Time dependency and reversibility. Environ. Toxicol Chem. 2002;21:767–775. doi: 10.1002/etc.5620210412. [DOI] [PubMed] [Google Scholar]
  • 41.Li L, Wojtowicz JL, Malin JH, Huang T, Lee EB, Chen Z. GnRH-mediated olfactory and visual inputs promote mating-like behaviors in male zebrafish. PLoS ONE. 2017;12:e0174143. doi: 10.1371/journal.pone.0174143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Salonia A, et al. Paediatric and adult-onset male hypogonadism. Nat. Rev. Dis. Primers. 2019;5:38. doi: 10.1038/s41572-019-0087-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Muller, M. N. Testosterone and reproductive effort in male primates. Horm. Behav.91, 36–51 (2017). [DOI] [PMC free article] [PubMed]
  • 44.Anderson RA, Bancroft J, Wu FC. The effects of exogenous testosterone on sexuality and mood of normal men. J. Clin. Endocrinol. Metab. 1992;75:1503–1507. doi: 10.1210/jcem.75.6.1464655. [DOI] [PubMed] [Google Scholar]
  • 45.Gray PB, McHale TS, Carre JM. A review of human male field studies of hormones and behavioral reproductive effort. Horm. Behav. 2017;91:52–67. doi: 10.1016/j.yhbeh.2016.07.004. [DOI] [PubMed] [Google Scholar]
  • 46.Fox, C. A., Ismai,l A. A., Love, D. N., Kirkham, K. E. & Loraine, J.A. Studies on the relationship between plasma testosterone levels and human sexual activity. J. Endocrinol.52, 51–58 (1972). [DOI] [PubMed]
  • 47.Davis SR, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol. Metab. 2001;12:33–37. doi: 10.1016/S1043-2760(00)00333-7. [DOI] [PubMed] [Google Scholar]
  • 48.Bolour S, Braunstein G. Testosterone therapy in women: A review. Int. J. Impot. Res. 2005;17:399–408. doi: 10.1038/sj.ijir.3901334. [DOI] [PubMed] [Google Scholar]
  • 49.Wallen K. Sex and context: Hormones and primate sexual motivation. Horm. Behav. 2001;40:339–357. doi: 10.1006/hbeh.2001.1696. [DOI] [PubMed] [Google Scholar]
  • 50.Johnson DF, Phoenix CH. Hormonal control of female sexual attractiveness, proceptivity, and receptivity in rhesus monkeys. J. Comp. Physiol. Psychol. 1976;90:473–483. doi: 10.1037/h0077216. [DOI] [PubMed] [Google Scholar]
  • 51.Reed, B. G., Bou Nemer, L. & Carr, B. R. Has testosterone passed the test in premenopausal women with low libido? A systematic review. Int. J. Women's Health 8, 599–607 (2016). [DOI] [PMC free article] [PubMed]
  • 52.Cappelletti M, Wallen K. Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens. Horm. Behav. 2016;78:178–193. doi: 10.1016/j.yhbeh.2015.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Miller SL, Maner JK. Scent of a woman: Men's testosterone responses to olfactory ovulation cues. Psychol. Sci. 2009;21:276–283. doi: 10.1177/0956797609357733. [DOI] [PubMed] [Google Scholar]
  • 54.Cheung CT, et al. What makes a bad egg? Egg transcriptome reveals dysregulation of translational machinery and novel fertility genes important for fertilization. BMC Genomics. 2019;20:584. doi: 10.1186/s12864-019-5930-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Zhai G, et al. Characterization of sexual trait development in cyp17a1-deficient zebrafish. Endocrinology. 2018;159:3549–3562. doi: 10.1210/en.2018-00551. [DOI] [PubMed] [Google Scholar]
  • 56.Hinfray N, et al. Dynamic and differential expression of the gonadal aromatase during the process of sexual differentiation in a novel transgenic cyp19a1a-eGFP zebrafish line. Gen. Comp. Endocrinol. 2018;261:179–189. doi: 10.1016/j.ygcen.2017.06.014. [DOI] [PubMed] [Google Scholar]
  • 57.Yang YJ, Wang Y, Li Z, Zhou L, Gui JF. Sequential, divergent, and cooperative requirements of Foxl2a and Foxl2b in ovary development and maintenance of zebrafish. Genetics. 2017;205:1551–1572. doi: 10.1534/genetics.116.199133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Connolly MH, Dutkosky RM, Heah TP, Sayler GS, Henry TB. Temporal dynamics of oocyte growth and vitellogenin gene expression in zebrafish (Danio rerio) Zebrafish. 2014;11:107–114. doi: 10.1089/zeb.2013.0938. [DOI] [PubMed] [Google Scholar]
  • 59.Peng, C., Clelland, E. & Tan, Q. Potential role of bone morphogenetic protein-15 in zebrafish follicle development and oocyte maturation. Comp. Biochem. Physiol. A Mol. Integr. Physiol.153, 83–87 (2009). [DOI] [PubMed]
  • 60.Dingare C, et al. The Hippo pathway effector Taz is required for cell morphogenesis and fertilization in zebrafish. Development. 2018;22:145. doi: 10.1242/dev.167023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Qin M, et al. Roles of Figla/Figla in juvenile ovary development and follicle formation during zebrafish gonadogenesis. Endocrinology. 2018;159:3699–3722. doi: 10.1210/en.2018-00648. [DOI] [PubMed] [Google Scholar]
  • 62.Wong QW, et al. Identification and characterization of a specific 13-miRNA expression signature during follicle activation in the zebrafish ovary. Biol. Reprod. 2018;98:42–53. doi: 10.1093/biolre/iox160. [DOI] [PubMed] [Google Scholar]
  • 63.Leerberg DM, Sano K, Draper BW. Fibroblast growth factor signaling is required for early somatic gonad development in zebrafish. PLoS Genet. 2017;13:e1006993. doi: 10.1371/journal.pgen.1006993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Wang P, Wang M, Ji G, Yang S, Zhang S, Liu Z. Demonstration of a functional Kisspeptin/Kisspeptin receptor system in amphioxus with implications for origin of neuroendocrine regulation. Endocrinology. 2017;158:1461–1473. doi: 10.1210/en.2016-1848. [DOI] [PubMed] [Google Scholar]
  • 65.Qi X, et al. Neurokinin B exerts direct effects on the ovary to stimulate estradiol production. Endocrinology. 2016;157:3355–3365. doi: 10.1210/en.2016-1354. [DOI] [PubMed] [Google Scholar]
  • 66.Zhu Y, Hua R, Zhou Y, Li H, Quan S, Yu Y. Chronic exposure to mono-(2-ethylhexyl)-phthalate causes endocrine disruption and reproductive dysfunction in zebrafish. Environ. Toxicol. Chem. 2016;35:2117–2124. doi: 10.1002/etc.3369. [DOI] [PubMed] [Google Scholar]
  • 67.Majumder S, Das S, Moulik SR, Mallick B, Pal P, Mukherjee D. G-protein coupled estrogen receptor (GPER) inhibits final oocyte maturation in common carp Cyprinus carpio. Gen. Comp. Endocrinol. 2015;211:28–38. doi: 10.1016/j.ygcen.2014.11.011. [DOI] [PubMed] [Google Scholar]
  • 68.Xu N, Chua AK, Jiang H, Liu NA, Goodarzi MO. Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes. Mol. Endocrinol. 2014;28:1329–1336. doi: 10.1210/me.2014-1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Brown HM, Russell DL. Blood and lymphatic vasculature in the ovary: Development, function and disease. Hum. Reprod. Update. 2014;20:29–39. doi: 10.1093/humupd/dmt049. [DOI] [PubMed] [Google Scholar]
  • 70.Zhang Z, Lau SW, Zhang L, Ge W. Disruption of zebrafish follicle-stimulating hormone receptor (fshr) but not luteinizing hormone receptor (lhcgr) gene by TALEN leads to failed follicle activation in females followed by sexual reversal to males. Endocrinology. 2015;156:3747–3762. doi: 10.1210/en.2015-1039. [DOI] [PubMed] [Google Scholar]
  • 71.Li J, Chu L, Sun X, Liu Y, Cheng CH. IGFs mediate the action of LH on oocyte maturation in zebrafish. Mol. Endocrinol. 2015;29:373–383. doi: 10.1210/me.2014-1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Chu L, Li J, Liu Y, Hu W, Cheng CH. Targeted gene disruption in zebrafish reveals noncanonical functions of LH signaling in reproduction. Mol. Endocrinol. 2014;28:1785–1795. doi: 10.1210/me.2014-1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Carnevali O, Gioacchini G, Maradonna F, Olivotto I, Migliarini B. Melatonin induces follicle maturation in Danio rerio. PLoS ONE. 2011;6:e19978. doi: 10.1371/journal.pone.0019978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Clelland E, Peng C. Endocrine/paracrine control of zebrafish ovarian development. Mol. Cell. Endocrinol. 2009;312:42–52. doi: 10.1016/j.mce.2009.04.009. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information. (332.6KB, docx)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES